Dextenza for Corneal Crosslinking

Conditions: Keratoconus Interventions: Drug: Dextenza 0.4Mg Ophthalmic Insert Sponsors: Maanasa Indaram, MD Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials